Knowing that the case of abortion tablets would probably have caused public indignation, Kacsmaryk took unusual measures to keep the proceedings in accordance with the wraps: usually details on the federal court are issued in the public list. But at a conference with lawyers on March 10, Kachsmarik said that he would try to postpone the announcement of the hearing until last night. However Washington Post I learned about the call in a day, providing a public warning about the upcoming hearing.
During the hearing of March 15, according to Washington PostKacsmaryk appeared open to the group’s complaints against abortion that mifepristone could be harmful or even fatal, and that the FDA approval process was a term.
“How many more women do you need to die?” The lawyer of the Abortion Group Eric Baptist asked during the hearing, according to Labbok avalanche-magazineField
In fact, scientific data categorically demonstrate that Mifepriston is safeThe field as of 2018, FDA data show 24 people out of 3.7 million He died after the adoption of Mifepriston, although their death could not be finally tied to the drug. The lawyers of the Ministry of Justice, who defended the FDA, said that 99.9% of Mifepristone users do not show serious side effects.
To order a ban on the approved FDA preparation is especially used that is so widely used for more than 20 years-it would be an unprecedented decision. Recognizing this, Kachsmarik asked the Baptist if he knows about any other decisions that removed the drug from the market, according to Associated pressAccording to the Baptist, there was not a single field, but he claimed that this was due to the “Stone” by the previous challenges of the drug.
In the “Normal World” Laurie CHETENThe senior lawyer of the state of the American project “Reproductive Freedom” of the American Civil Freedoms Union was announced by Buzzfeed News, the upcoming hearing on March 15, a lawsuit to combat abortions would be excluded from the very beginning. The fact that this was not a show, we entered the “unknown waters,” she said.
“What the plaintiffs asked here is unprecedented,” Chaten said. “The courts simply do not jump and do not remove drugs from the market, especially not those on the market [23 years].
On the eve of the arguments in the case of Texas, the state under the leadership of the Democrats sued FDA At the end of February, in the U.S. District Court in the Eastern District, Washington. The complaint first of all asked the court to order the agency to delete an additional level of restrictions on mifepriston. But he also searched for a decision that orders the agency “to take some kind of action to remove the mifepristone from the market or to reduce its availability.” On Friday District Judge Thomas Owen Rice, an appointed person Barack ObamaThis was exactly what, having discovered that the preliminary judicial ban was in public interests.
Nevertheless, Rice wrote that the national trial in this case was “inappropriate”, referring to the competing trial in Texas.
Although it remains unclear how the Supreme Court will understand the differences in two opinions, the influence of the decision of the Kachsmari, which should be felt throughout the country – if he is allowed to enter into force.
“Even in the states where an abortion is legal, if it is an unstressed drug, there may be legal consequences to continue prescribing it and, of course, for these sponsors to continue to distribute it,” Chaten said.
David Mack and Stefani K. Baer contributed to this story.
